nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefdinir—MPO—Carboplatin—brain cancer	0.621	1	CbGbCtD
Cefdinir—Bleeding tendency—Procarbazine—brain cancer	0.0408	0.135	CcSEcCtD
Cefdinir—SLC15A2—choroid plexus—brain cancer	0.0274	0.382	CbGeAlD
Cefdinir—Haemorrhagic disorder—Procarbazine—brain cancer	0.0134	0.0444	CcSEcCtD
Cefdinir—Nephropathy toxic—Lomustine—brain cancer	0.00931	0.0308	CcSEcCtD
Cefdinir—MPO—endothelium—brain cancer	0.00621	0.0865	CbGeAlD
Cefdinir—MPO—blood vessel—brain cancer	0.00572	0.0797	CbGeAlD
Cefdinir—Cefazolin—PON1—brain cancer	0.00432	1	CrCbGaD
Cefdinir—Interstitial pneumonia—Temozolomide—brain cancer	0.00425	0.014	CcSEcCtD
Cefdinir—Digestion impaired—Hydroxyurea—brain cancer	0.00393	0.013	CcSEcCtD
Cefdinir—Nephropathy toxic—Carmustine—brain cancer	0.0037	0.0122	CcSEcCtD
Cefdinir—Nephropathy—Etoposide—brain cancer	0.00345	0.0114	CcSEcCtD
Cefdinir—Interstitial pneumonia—Etoposide—brain cancer	0.0034	0.0112	CcSEcCtD
Cefdinir—Melaena—Procarbazine—brain cancer	0.00332	0.011	CcSEcCtD
Cefdinir—Pancytopenia—Lomustine—brain cancer	0.00319	0.0105	CcSEcCtD
Cefdinir—Digestion impaired—Temozolomide—brain cancer	0.00307	0.0102	CcSEcCtD
Cefdinir—Interstitial lung disease—Carmustine—brain cancer	0.003	0.00992	CcSEcCtD
Cefdinir—Renal failure—Lomustine—brain cancer	0.00294	0.00972	CcSEcCtD
Cefdinir—Stomatitis—Lomustine—brain cancer	0.00292	0.00964	CcSEcCtD
Cefdinir—Interstitial lung disease—Temozolomide—brain cancer	0.0029	0.00959	CcSEcCtD
Cefdinir—Nephropathy toxic—Etoposide—brain cancer	0.00286	0.00946	CcSEcCtD
Cefdinir—Hepatic function abnormal—Procarbazine—brain cancer	0.00282	0.00932	CcSEcCtD
Cefdinir—Haemolytic anaemia—Procarbazine—brain cancer	0.00273	0.00903	CcSEcCtD
Cefdinir—Cholestasis—Temozolomide—brain cancer	0.0027	0.00894	CcSEcCtD
Cefdinir—Haemoglobin—Lomustine—brain cancer	0.0027	0.00892	CcSEcCtD
Cefdinir—Haemorrhage—Lomustine—brain cancer	0.00269	0.00888	CcSEcCtD
Cefdinir—Coagulopathy—Temozolomide—brain cancer	0.00264	0.00872	CcSEcCtD
Cefdinir—Purpura—Procarbazine—brain cancer	0.00256	0.00845	CcSEcCtD
Cefdinir—Rash maculo-papular—Hydroxyurea—brain cancer	0.00239	0.0079	CcSEcCtD
Cefdinir—Interstitial lung disease—Etoposide—brain cancer	0.00232	0.00767	CcSEcCtD
Cefdinir—MPO—pituitary gland—brain cancer	0.00226	0.0315	CbGeAlD
Cefdinir—Toxic epidermal necrolysis—Procarbazine—brain cancer	0.00222	0.00734	CcSEcCtD
Cefdinir—Hepatic failure—Hydroxyurea—brain cancer	0.00212	0.00702	CcSEcCtD
Cefdinir—Leukopenia—Lomustine—brain cancer	0.00209	0.00692	CcSEcCtD
Cefdinir—Renal failure acute—Hydroxyurea—brain cancer	0.00207	0.00683	CcSEcCtD
Cefdinir—Vaginal inflammation—Temozolomide—brain cancer	0.00205	0.00679	CcSEcCtD
Cefdinir—Candida infection—Carmustine—brain cancer	0.00203	0.0067	CcSEcCtD
Cefdinir—Pancytopenia—Procarbazine—brain cancer	0.00202	0.00669	CcSEcCtD
Cefdinir—Candida infection—Temozolomide—brain cancer	0.00196	0.00648	CcSEcCtD
Cefdinir—SLC15A1—endocrine gland—brain cancer	0.00195	0.0271	CbGeAlD
Cefdinir—MPO—spinal cord—brain cancer	0.00195	0.0271	CbGeAlD
Cefdinir—Vaginal infection—Temozolomide—brain cancer	0.00194	0.00641	CcSEcCtD
Cefdinir—SLC15A2—telencephalon—brain cancer	0.00193	0.0269	CbGeAlD
Cefdinir—Aplastic anaemia—Temozolomide—brain cancer	0.00193	0.00637	CcSEcCtD
Cefdinir—Pneumonia—Procarbazine—brain cancer	0.00191	0.00632	CcSEcCtD
Cefdinir—Thrombocytopenia—Lomustine—brain cancer	0.00187	0.00618	CcSEcCtD
Cefdinir—Jaundice—Procarbazine—brain cancer	0.00185	0.00612	CcSEcCtD
Cefdinir—Stomatitis—Procarbazine—brain cancer	0.00185	0.00612	CcSEcCtD
Cefdinir—Anorexia—Lomustine—brain cancer	0.00182	0.00601	CcSEcCtD
Cefdinir—Haematuria—Procarbazine—brain cancer	0.00181	0.00599	CcSEcCtD
Cefdinir—MPO—endocrine gland—brain cancer	0.00175	0.0244	CbGeAlD
Cefdinir—MPO—head—brain cancer	0.00173	0.0241	CbGeAlD
Cefdinir—Body temperature increased—Carboplatin—brain cancer	0.00172	0.0057	CcSEcCtD
Cefdinir—Haemoglobin—Procarbazine—brain cancer	0.00171	0.00567	CcSEcCtD
Cefdinir—Haemorrhage—Procarbazine—brain cancer	0.00171	0.00564	CcSEcCtD
Cefdinir—Decreased appetite—Lomustine—brain cancer	0.00166	0.00548	CcSEcCtD
Cefdinir—Hepatic failure—Temozolomide—brain cancer	0.00166	0.00548	CcSEcCtD
Cefdinir—Dermatitis exfoliative—Temozolomide—brain cancer	0.00158	0.00522	CcSEcCtD
Cefdinir—MPO—central nervous system—brain cancer	0.00158	0.022	CbGeAlD
Cefdinir—SLC15A2—pituitary gland—brain cancer	0.00157	0.0219	CbGeAlD
Cefdinir—Candida infection—Etoposide—brain cancer	0.00157	0.00518	CcSEcCtD
Cefdinir—Pancytopenia—Hydroxyurea—brain cancer	0.00157	0.00518	CcSEcCtD
Cefdinir—Purpura—Temozolomide—brain cancer	0.00155	0.00511	CcSEcCtD
Cefdinir—Neutropenia—Hydroxyurea—brain cancer	0.00154	0.0051	CcSEcCtD
Cefdinir—SLC15A2—medulla oblongata—brain cancer	0.00152	0.0211	CbGeAlD
Cefdinir—Body temperature increased—Lomustine—brain cancer	0.00151	0.00499	CcSEcCtD
Cefdinir—Rash maculo-papular—Etoposide—brain cancer	0.00149	0.00494	CcSEcCtD
Cefdinir—Stomatitis—Hydroxyurea—brain cancer	0.00143	0.00474	CcSEcCtD
Cefdinir—SLC15A2—midbrain—brain cancer	0.00139	0.0193	CbGeAlD
Cefdinir—SLC22A5—pituitary gland—brain cancer	0.00137	0.019	CbGeAlD
Cefdinir—SLC15A2—spinal cord—brain cancer	0.00135	0.0188	CbGeAlD
Cefdinir—Aspartate aminotransferase increased—Temozolomide—brain cancer	0.00134	0.00444	CcSEcCtD
Cefdinir—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.00134	0.00444	CcSEcCtD
Cefdinir—Leukopenia—Procarbazine—brain cancer	0.00133	0.00439	CcSEcCtD
Cefdinir—Haemoglobin—Hydroxyurea—brain cancer	0.00133	0.00438	CcSEcCtD
Cefdinir—Haemorrhage—Hydroxyurea—brain cancer	0.00132	0.00436	CcSEcCtD
Cefdinir—SLC22A5—medulla oblongata—brain cancer	0.00132	0.0184	CbGeAlD
Cefdinir—Loss of consciousness—Procarbazine—brain cancer	0.0013	0.00431	CcSEcCtD
Cefdinir—Convulsion—Procarbazine—brain cancer	0.00129	0.00425	CcSEcCtD
Cefdinir—Hypertension—Procarbazine—brain cancer	0.00128	0.00424	CcSEcCtD
Cefdinir—Pancytopenia—Carmustine—brain cancer	0.00127	0.00418	CcSEcCtD
Cefdinir—MPO—brain—brain cancer	0.00125	0.0175	CbGeAlD
Cefdinir—Neutropenia—Carmustine—brain cancer	0.00125	0.00412	CcSEcCtD
Cefdinir—Dry mouth—Procarbazine—brain cancer	0.00124	0.00409	CcSEcCtD
Cefdinir—Pancytopenia—Temozolomide—brain cancer	0.00122	0.00404	CcSEcCtD
Cefdinir—Cardiac failure—Etoposide—brain cancer	0.00122	0.00404	CcSEcCtD
Cefdinir—SLC15A2—endocrine gland—brain cancer	0.00122	0.017	CbGeAlD
Cefdinir—Vomiting—Lomustine—brain cancer	0.00121	0.00401	CcSEcCtD
Cefdinir—SLC22A5—midbrain—brain cancer	0.0012	0.0168	CbGeAlD
Cefdinir—Neutropenia—Temozolomide—brain cancer	0.0012	0.00398	CcSEcCtD
Cefdinir—SLC15A2—head—brain cancer	0.0012	0.0167	CbGeAlD
Cefdinir—Pneumonia—Carmustine—brain cancer	0.0012	0.00395	CcSEcCtD
Cefdinir—Shock—Procarbazine—brain cancer	0.00119	0.00394	CcSEcCtD
Cefdinir—Thrombocytopenia—Procarbazine—brain cancer	0.00119	0.00392	CcSEcCtD
Cefdinir—SLC22A5—spinal cord—brain cancer	0.00118	0.0164	CbGeAlD
Cefdinir—Renal failure—Carmustine—brain cancer	0.00117	0.00386	CcSEcCtD
Cefdinir—Stomatitis—Carmustine—brain cancer	0.00116	0.00383	CcSEcCtD
Cefdinir—Pneumonia—Temozolomide—brain cancer	0.00116	0.00382	CcSEcCtD
Cefdinir—Anorexia—Procarbazine—brain cancer	0.00115	0.00382	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.00114	0.00376	CcSEcCtD
Cefdinir—Nausea—Lomustine—brain cancer	0.00113	0.00375	CcSEcCtD
Cefdinir—Stomatitis—Temozolomide—brain cancer	0.00112	0.0037	CcSEcCtD
Cefdinir—SLC15A2—central nervous system—brain cancer	0.0011	0.0153	CbGeAlD
Cefdinir—Insomnia—Procarbazine—brain cancer	0.0011	0.00362	CcSEcCtD
Cefdinir—Somnolence—Procarbazine—brain cancer	0.00108	0.00356	CcSEcCtD
Cefdinir—Toxic epidermal necrolysis—Etoposide—brain cancer	0.00107	0.00355	CcSEcCtD
Cefdinir—Haemoglobin—Carmustine—brain cancer	0.00107	0.00354	CcSEcCtD
Cefdinir—SLC15A2—cerebellum—brain cancer	0.00107	0.0149	CbGeAlD
Cefdinir—Haemorrhage—Carmustine—brain cancer	0.00107	0.00353	CcSEcCtD
Cefdinir—Decreased appetite—Procarbazine—brain cancer	0.00105	0.00348	CcSEcCtD
Cefdinir—Haemoglobin—Temozolomide—brain cancer	0.00104	0.00343	CcSEcCtD
Cefdinir—Constipation—Procarbazine—brain cancer	0.00104	0.00342	CcSEcCtD
Cefdinir—Haemorrhage—Temozolomide—brain cancer	0.00103	0.00341	CcSEcCtD
Cefdinir—Leukopenia—Hydroxyurea—brain cancer	0.00103	0.0034	CcSEcCtD
Cefdinir—Convulsion—Hydroxyurea—brain cancer	0.000996	0.00329	CcSEcCtD
Cefdinir—Gastrointestinal pain—Procarbazine—brain cancer	0.000991	0.00327	CcSEcCtD
Cefdinir—Pancytopenia—Etoposide—brain cancer	0.000979	0.00324	CcSEcCtD
Cefdinir—Erythema multiforme—Temozolomide—brain cancer	0.000975	0.00322	CcSEcCtD
Cefdinir—Neutropenia—Etoposide—brain cancer	0.000964	0.00319	CcSEcCtD
Cefdinir—Abdominal pain—Procarbazine—brain cancer	0.000958	0.00317	CcSEcCtD
Cefdinir—Body temperature increased—Procarbazine—brain cancer	0.000958	0.00317	CcSEcCtD
Cefdinir—SLC22A5—cerebellum—brain cancer	0.000932	0.013	CbGeAlD
Cefdinir—Pneumonia—Etoposide—brain cancer	0.000924	0.00306	CcSEcCtD
Cefdinir—Thrombocytopenia—Hydroxyurea—brain cancer	0.000918	0.00303	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000911	0.00301	CcSEcCtD
Cefdinir—Acute coronary syndrome—Etoposide—brain cancer	0.000906	0.00299	CcSEcCtD
Cefdinir—Renal failure—Etoposide—brain cancer	0.000904	0.00299	CcSEcCtD
Cefdinir—Myocardial infarction—Etoposide—brain cancer	0.000901	0.00298	CcSEcCtD
Cefdinir—Stomatitis—Etoposide—brain cancer	0.000896	0.00296	CcSEcCtD
Cefdinir—Jaundice—Etoposide—brain cancer	0.000896	0.00296	CcSEcCtD
Cefdinir—Anorexia—Hydroxyurea—brain cancer	0.000894	0.00295	CcSEcCtD
Cefdinir—Hypersensitivity—Procarbazine—brain cancer	0.000893	0.00295	CcSEcCtD
Cefdinir—SLC15A2—brain—brain cancer	0.00087	0.0121	CbGeAlD
Cefdinir—Asthenia—Procarbazine—brain cancer	0.000869	0.00287	CcSEcCtD
Cefdinir—Agranulocytosis—Etoposide—brain cancer	0.000858	0.00284	CcSEcCtD
Cefdinir—Pruritus—Procarbazine—brain cancer	0.000857	0.00283	CcSEcCtD
Cefdinir—Agitation—Carmustine—brain cancer	0.000854	0.00282	CcSEcCtD
Cefdinir—Somnolence—Hydroxyurea—brain cancer	0.000834	0.00276	CcSEcCtD
Cefdinir—Leukopenia—Carmustine—brain cancer	0.000831	0.00275	CcSEcCtD
Cefdinir—Diarrhoea—Procarbazine—brain cancer	0.000829	0.00274	CcSEcCtD
Cefdinir—Dyspepsia—Hydroxyurea—brain cancer	0.000825	0.00273	CcSEcCtD
Cefdinir—Agitation—Temozolomide—brain cancer	0.000825	0.00273	CcSEcCtD
Cefdinir—Decreased appetite—Hydroxyurea—brain cancer	0.000815	0.00269	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00081	0.00268	CcSEcCtD
Cefdinir—Convulsion—Carmustine—brain cancer	0.000805	0.00266	CcSEcCtD
Cefdinir—Leukopenia—Temozolomide—brain cancer	0.000803	0.00266	CcSEcCtD
Cefdinir—Hypertension—Carmustine—brain cancer	0.000802	0.00265	CcSEcCtD
Cefdinir—Constipation—Hydroxyurea—brain cancer	0.000802	0.00265	CcSEcCtD
Cefdinir—Dizziness—Procarbazine—brain cancer	0.000801	0.00265	CcSEcCtD
Cefdinir—Chest pain—Carmustine—brain cancer	0.000791	0.00261	CcSEcCtD
Cefdinir—Erythema multiforme—Etoposide—brain cancer	0.00078	0.00258	CcSEcCtD
Cefdinir—Convulsion—Temozolomide—brain cancer	0.000778	0.00257	CcSEcCtD
Cefdinir—Hypertension—Temozolomide—brain cancer	0.000775	0.00256	CcSEcCtD
Cefdinir—Vomiting—Procarbazine—brain cancer	0.00077	0.00255	CcSEcCtD
Cefdinir—Rash—Procarbazine—brain cancer	0.000764	0.00253	CcSEcCtD
Cefdinir—Dermatitis—Procarbazine—brain cancer	0.000763	0.00252	CcSEcCtD
Cefdinir—Headache—Procarbazine—brain cancer	0.000759	0.00251	CcSEcCtD
Cefdinir—SLC22A5—brain—brain cancer	0.000757	0.0105	CbGeAlD
Cefdinir—Dry mouth—Temozolomide—brain cancer	0.000747	0.00247	CcSEcCtD
Cefdinir—Thrombocytopenia—Carmustine—brain cancer	0.000742	0.00245	CcSEcCtD
Cefdinir—Body temperature increased—Hydroxyurea—brain cancer	0.000741	0.00245	CcSEcCtD
Cefdinir—Anaphylactic shock—Temozolomide—brain cancer	0.000733	0.00242	CcSEcCtD
Cefdinir—Anorexia—Carmustine—brain cancer	0.000723	0.00239	CcSEcCtD
Cefdinir—Nausea—Procarbazine—brain cancer	0.00072	0.00238	CcSEcCtD
Cefdinir—Thrombocytopenia—Temozolomide—brain cancer	0.000717	0.00237	CcSEcCtD
Cefdinir—Anorexia—Temozolomide—brain cancer	0.000698	0.00231	CcSEcCtD
Cefdinir—Hypersensitivity—Hydroxyurea—brain cancer	0.000691	0.00228	CcSEcCtD
Cefdinir—Insomnia—Carmustine—brain cancer	0.000686	0.00227	CcSEcCtD
Cefdinir—Somnolence—Carmustine—brain cancer	0.000674	0.00223	CcSEcCtD
Cefdinir—Asthenia—Hydroxyurea—brain cancer	0.000673	0.00222	CcSEcCtD
Cefdinir—Insomnia—Temozolomide—brain cancer	0.000663	0.00219	CcSEcCtD
Cefdinir—Decreased appetite—Carmustine—brain cancer	0.000659	0.00218	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Carmustine—brain cancer	0.000654	0.00216	CcSEcCtD
Cefdinir—Somnolence—Temozolomide—brain cancer	0.000651	0.00215	CcSEcCtD
Cefdinir—Constipation—Carmustine—brain cancer	0.000648	0.00214	CcSEcCtD
Cefdinir—Dyspepsia—Temozolomide—brain cancer	0.000645	0.00213	CcSEcCtD
Cefdinir—Leukopenia—Etoposide—brain cancer	0.000643	0.00213	CcSEcCtD
Cefdinir—Diarrhoea—Hydroxyurea—brain cancer	0.000642	0.00212	CcSEcCtD
Cefdinir—Decreased appetite—Temozolomide—brain cancer	0.000637	0.0021	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Temozolomide—brain cancer	0.000632	0.00209	CcSEcCtD
Cefdinir—Loss of consciousness—Etoposide—brain cancer	0.000631	0.00209	CcSEcCtD
Cefdinir—Constipation—Temozolomide—brain cancer	0.000626	0.00207	CcSEcCtD
Cefdinir—Convulsion—Etoposide—brain cancer	0.000622	0.00206	CcSEcCtD
Cefdinir—Hypertension—Etoposide—brain cancer	0.00062	0.00205	CcSEcCtD
Cefdinir—Dizziness—Hydroxyurea—brain cancer	0.00062	0.00205	CcSEcCtD
Cefdinir—Gastrointestinal pain—Carmustine—brain cancer	0.00062	0.00205	CcSEcCtD
Cefdinir—Chest pain—Etoposide—brain cancer	0.000612	0.00202	CcSEcCtD
Cefdinir—Abdominal pain—Carmustine—brain cancer	0.000599	0.00198	CcSEcCtD
Cefdinir—Body temperature increased—Carmustine—brain cancer	0.000599	0.00198	CcSEcCtD
Cefdinir—Gastrointestinal pain—Temozolomide—brain cancer	0.000599	0.00198	CcSEcCtD
Cefdinir—Vomiting—Hydroxyurea—brain cancer	0.000596	0.00197	CcSEcCtD
Cefdinir—Rash—Hydroxyurea—brain cancer	0.000591	0.00195	CcSEcCtD
Cefdinir—Dermatitis—Hydroxyurea—brain cancer	0.000591	0.00195	CcSEcCtD
Cefdinir—Headache—Hydroxyurea—brain cancer	0.000587	0.00194	CcSEcCtD
Cefdinir—Anaphylactic shock—Etoposide—brain cancer	0.000586	0.00194	CcSEcCtD
Cefdinir—Abdominal pain—Temozolomide—brain cancer	0.000579	0.00191	CcSEcCtD
Cefdinir—Body temperature increased—Temozolomide—brain cancer	0.000579	0.00191	CcSEcCtD
Cefdinir—Thrombocytopenia—Etoposide—brain cancer	0.000574	0.0019	CcSEcCtD
Cefdinir—Anorexia—Etoposide—brain cancer	0.000559	0.00185	CcSEcCtD
Cefdinir—Hypersensitivity—Carmustine—brain cancer	0.000559	0.00185	CcSEcCtD
Cefdinir—Nausea—Hydroxyurea—brain cancer	0.000557	0.00184	CcSEcCtD
Cefdinir—Asthenia—Carmustine—brain cancer	0.000544	0.0018	CcSEcCtD
Cefdinir—Hypersensitivity—Temozolomide—brain cancer	0.00054	0.00178	CcSEcCtD
Cefdinir—Asthenia—Temozolomide—brain cancer	0.000526	0.00174	CcSEcCtD
Cefdinir—Somnolence—Etoposide—brain cancer	0.000521	0.00172	CcSEcCtD
Cefdinir—Diarrhoea—Carmustine—brain cancer	0.000519	0.00171	CcSEcCtD
Cefdinir—Pruritus—Temozolomide—brain cancer	0.000518	0.00171	CcSEcCtD
Cefdinir—Decreased appetite—Etoposide—brain cancer	0.00051	0.00168	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Etoposide—brain cancer	0.000506	0.00167	CcSEcCtD
Cefdinir—Dizziness—Carmustine—brain cancer	0.000501	0.00166	CcSEcCtD
Cefdinir—Constipation—Etoposide—brain cancer	0.000501	0.00166	CcSEcCtD
Cefdinir—Diarrhoea—Temozolomide—brain cancer	0.000501	0.00166	CcSEcCtD
Cefdinir—Dizziness—Temozolomide—brain cancer	0.000484	0.0016	CcSEcCtD
Cefdinir—Vomiting—Carmustine—brain cancer	0.000482	0.00159	CcSEcCtD
Cefdinir—Gastrointestinal pain—Etoposide—brain cancer	0.000479	0.00158	CcSEcCtD
Cefdinir—Rash—Carmustine—brain cancer	0.000478	0.00158	CcSEcCtD
Cefdinir—Dermatitis—Carmustine—brain cancer	0.000478	0.00158	CcSEcCtD
Cefdinir—Headache—Carmustine—brain cancer	0.000475	0.00157	CcSEcCtD
Cefdinir—Vomiting—Temozolomide—brain cancer	0.000466	0.00154	CcSEcCtD
Cefdinir—Abdominal pain—Etoposide—brain cancer	0.000463	0.00153	CcSEcCtD
Cefdinir—Body temperature increased—Etoposide—brain cancer	0.000463	0.00153	CcSEcCtD
Cefdinir—Rash—Temozolomide—brain cancer	0.000462	0.00153	CcSEcCtD
Cefdinir—Dermatitis—Temozolomide—brain cancer	0.000461	0.00153	CcSEcCtD
Cefdinir—Headache—Temozolomide—brain cancer	0.000459	0.00152	CcSEcCtD
Cefdinir—Nausea—Carmustine—brain cancer	0.00045	0.00149	CcSEcCtD
Cefdinir—Nausea—Temozolomide—brain cancer	0.000435	0.00144	CcSEcCtD
Cefdinir—Hypersensitivity—Etoposide—brain cancer	0.000432	0.00143	CcSEcCtD
Cefdinir—Asthenia—Etoposide—brain cancer	0.000421	0.00139	CcSEcCtD
Cefdinir—Pruritus—Etoposide—brain cancer	0.000415	0.00137	CcSEcCtD
Cefdinir—Diarrhoea—Etoposide—brain cancer	0.000401	0.00133	CcSEcCtD
Cefdinir—Dizziness—Etoposide—brain cancer	0.000388	0.00128	CcSEcCtD
Cefdinir—Vomiting—Etoposide—brain cancer	0.000373	0.00123	CcSEcCtD
Cefdinir—Rash—Etoposide—brain cancer	0.00037	0.00122	CcSEcCtD
Cefdinir—Dermatitis—Etoposide—brain cancer	0.000369	0.00122	CcSEcCtD
Cefdinir—Headache—Etoposide—brain cancer	0.000367	0.00121	CcSEcCtD
Cefdinir—Nausea—Etoposide—brain cancer	0.000348	0.00115	CcSEcCtD
